Kun:LabNotes/inSituSeq: Difference between revisions
Jump to navigation
Jump to search
m (→Probe design) |
m (→Probe design) |
||
Line 12: | Line 12: | ||
#Avoid alternatively spliced exons. | #Avoid alternatively spliced exons. | ||
*Considerations: | *Considerations: | ||
#Targeting RNA versus cDNA; | #Targeting RNA versus cDNA (RNA: one fewer step, more specific, efficiency could depends on secondary structure; DNA: one more step, can be immobilized, secondary structure could be less a problem); | ||
#Targeting nuclear transcripts versus cytoplasmic transcripts; | #Targeting nuclear transcripts versus cytoplasmic transcripts (space available for imaging, integration with single-cell toto-RNAseq data); | ||
#Targeting 3'-ends or random positions; | #Targeting 3'-ends or random positions (affects how cDNAs are generated, poly-T primed or N6/9 primed); | ||
#Gap versus no gap; | #Gap versus no gap (Specificity versus sensitivity); | ||
#Targeting single exons or across splice junctions; | #Targeting single exons or across splice junctions (mature transcripts versus nascent transcripts or gDNA); | ||
*Constrains: | *Constrains: | ||
#We can get only up to 240bp oligos from Agilent for now. | #We can get only up to 240bp oligos from Agilent for now. |
Revision as of 23:45, 9 October 2012
RNA in situ sequencing
Responsibilities
- Rui: in situ rolony generation
- Matt: design and testing of decoding padlock probes
- Ho Suk: instrumentation (fluidic devices), automation, image analysis
Method developments
Probe design
- Strategy: Experimentally evaluate the capture efficiencies of 55,000 probes, and pick the best ones.
- Choice of genes:
- Variable expression among different brain regions and cell types.
- Moderate abundance (too low: difficult to detect; too high: rolonies too crowded and difficult to resolve optically).
- Avoid alternatively spliced exons.
- Considerations:
- Targeting RNA versus cDNA (RNA: one fewer step, more specific, efficiency could depends on secondary structure; DNA: one more step, can be immobilized, secondary structure could be less a problem);
- Targeting nuclear transcripts versus cytoplasmic transcripts (space available for imaging, integration with single-cell toto-RNAseq data);
- Targeting 3'-ends or random positions (affects how cDNAs are generated, poly-T primed or N6/9 primed);
- Gap versus no gap (Specificity versus sensitivity);
- Targeting single exons or across splice junctions (mature transcripts versus nascent transcripts or gDNA);
- Constrains:
- We can get only up to 240bp oligos from Agilent for now.
- A minimal list of features on the probes:
- Amplification adaptors (36-44bp, depending on the probe prep protocol).
- Common linker (48bp for our standard linker sequence, need to be reduced significantly, which is fine since we will be doing RCA instead of PCR and only a short annealing region is enough)
- Decoding region (6x20bp=120bp)
- Capturing arms (40-50bp, need to set an upper limit)
Rolonies generation
- Considerations:
- Direct padlock capture versus whole transcriptome amplification